Literature DB >> 27848180

Iron overload patients with unknown etiology from national survey in Japan.

Katsuya Ikuta1, Mayumi Hatayama2, Lynda Addo2, Yasumichi Toki2, Katsunori Sasaki3, Yasuaki Tatsumi4, Ai Hattori4,5, Ayako Kato4, Koichi Kato4, Hisao Hayashi4, Takahiro Suzuki6, Masayoshi Kobune7, Miyuki Tsutsui8, Akihiko Gotoh8, Yasuo Aota9, Motoo Matsuura10, Yuzuru Hamada11, Takahiro Tokuda12, Norio Komatsu8, Yutaka Kohgo2,13.   

Abstract

Transfusion is believed to be the main cause of iron overload in Japan. A nationwide survey on post-transfusional iron overload subsequently led to the establishment of guidelines for iron chelation therapy in this country. To date, however, detailed clinical information on the entire iron overload population in Japan has not been fully investigated. In the present study, we obtained and studied detailed clinical information on the iron overload patient population in Japan. Of 1109 iron overload cases, 93.1% were considered to have occurred post-transfusion. There were, however, 76 cases of iron overload of unknown origin, which suggest that many clinicians in Japan may encounter some difficulty in correctly diagnosing and treating iron overload. Further clinical data were obtained for 32 cases of iron overload of unknown origin; median of serum ferritin was 1860.5 ng/mL. As occurs in post-transfusional iron overload, liver dysfunction was found to be as high as 95.7% when serum ferritin levels exceeded 1000 ng/mL in these patients. Gene mutation analysis of the iron metabolism-related genes in 27 cases of iron overload with unknown etiology revealed mutations in the gene coding hemojuvelin, transferrin receptor 2, and ferroportin; this indicates that although rare, hereditary hemochromatosis does occur in Japan.

Entities:  

Keywords:  Hemochromatosis; Hereditary hemochromatosis; Iron overload; Post-transfusional iron overload

Mesh:

Substances:

Year:  2016        PMID: 27848180     DOI: 10.1007/s12185-016-2141-9

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  28 in total

1.  Global prevalence of putative haemochromatosis mutations.

Authors:  A T Merryweather-Clarke; J J Pointon; J D Shearman; K J Robson
Journal:  J Med Genet       Date:  1997-04       Impact factor: 6.318

2.  A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis.

Authors:  J N Feder; A Gnirke; W Thomas; Z Tsuchihashi; D A Ruddy; A Basava; F Dormishian; R Domingo; M C Ellis; A Fullan; L M Hinton; N L Jones; B E Kimmel; G S Kronmal; P Lauer; V K Lee; D B Loeb; F A Mapa; E McClelland; N C Meyer; G A Mintier; N Moeller; T Moore; E Morikang; C E Prass; L Quintana; S M Starnes; R C Schatzman; K J Brunke; D T Drayna; N J Risch; B R Bacon; R K Wolff
Journal:  Nat Genet       Date:  1996-08       Impact factor: 38.330

Review 3.  Hereditary hemochromatosis: pathogenesis, diagnosis, and treatment.

Authors:  Antonello Pietrangelo
Journal:  Gastroenterology       Date:  2010-06-11       Impact factor: 22.682

4.  Primary iron overload with inappropriate hepcidin expression in V162del ferroportin disease.

Authors:  Heinz Zoller; Ian McFarlane; Igor Theurl; Sylvia Stadlmann; Elizabeta Nemeth; David Oxley; Tomas Ganz; David J Halsall; Timothy M Cox; Wolfgang Vogel
Journal:  Hepatology       Date:  2005-08       Impact factor: 17.425

5.  Two novel mutations, L490R and V561X, of the transferrin receptor 2 gene in Japanese patients with hemochromatosis.

Authors:  Chizu Koyama; Shinya Wakusawa; Hisao Hayashi; Rie Suzuki; Motoyoshi Yano; Kentaro Yoshioka; Mitsuo Kozuru; Yoshihiro Takayamam; Toshihide Okada; Hiroshi Mabuchi
Journal:  Haematologica       Date:  2005-03       Impact factor: 9.941

6.  Identification of a human mutation of DMT1 in a patient with microcytic anemia and iron overload.

Authors:  Martha P Mims; Yongli Guan; Dagmar Pospisilova; Monika Priwitzerova; Karel Indrak; Prem Ponka; Vladimir Divoky; Josef T Prchal
Journal:  Blood       Date:  2004-09-30       Impact factor: 22.113

7.  Retrospective nationwide survey of Japanese patients with transfusion-dependent MDS and aplastic anemia highlights the negative impact of iron overload on morbidity/mortality.

Authors:  Masaaki Takatoku; Takashi Uchiyama; Shinichiro Okamoto; Yuzuru Kanakura; Kenichi Sawada; Masao Tomonaga; Shinji Nakao; Tatsutoshi Nakahata; Mine Harada; Takashi Murate; Keiya Ozawa
Journal:  Eur J Haematol       Date:  2007-03-28       Impact factor: 2.997

8.  Clinicopathological study of Japanese patients with genetic iron overload syndromes.

Authors:  Ai Hattori; Hiroaki Miyajima; Naohisa Tomosugi; Yasuaki Tatsumi; Hisao Hayashi; Shinya Wakusawa
Journal:  Pathol Int       Date:  2012-09       Impact factor: 2.534

Review 9.  Systemic iron homeostasis.

Authors:  Tomas Ganz
Journal:  Physiol Rev       Date:  2013-10       Impact factor: 37.312

10.  Hepcidin is decreased in TFR2 hemochromatosis.

Authors:  Elizabeta Nemeth; Antonella Roetto; Giovanni Garozzo; Tomas Ganz; Clara Camaschella
Journal:  Blood       Date:  2004-10-14       Impact factor: 22.113

View more
  6 in total

Review 1.  The mechanisms of systemic iron homeostasis and etiology, diagnosis, and treatment of hereditary hemochromatosis.

Authors:  Hiroshi Kawabata
Journal:  Int J Hematol       Date:  2017-11-13       Impact factor: 2.490

Review 2.  Ethnic Differences in Iron Status.

Authors:  Wanhui Kang; Alexa Barad; Andrew G Clark; Yiqin Wang; Xu Lin; Zhenglong Gu; Kimberly O O'Brien
Journal:  Adv Nutr       Date:  2021-10-01       Impact factor: 8.701

Review 3.  Genotypic and phenotypic spectra of hemojuvelin mutations in primary hemochromatosis patients: a systematic review.

Authors:  Xiaomu Kong; Lingding Xie; Haiqing Zhu; Lulu Song; Xiaoyan Xing; Wenying Yang; Xiaoping Chen
Journal:  Orphanet J Rare Dis       Date:  2019-07-08       Impact factor: 4.123

4.  HFE-Related Hemochromatosis in a Chinese Patient: The First Reported Case.

Authors:  Wei Zhang; Xiaoming Wang; Weijia Duan; Anjian Xu; Xinyan Zhao; Jian Huang; Hong You; Pierre Brissot; Xiaojuan Ou; Jidong Jia
Journal:  Front Genet       Date:  2020-02-21       Impact factor: 4.599

5.  Iron Overload and the Risk of Diabetes in the General Population: Results of the Chinese Health and Nutrition Survey Cohort Study.

Authors:  He Gao; Jinying Yang; Wenfei Pan; Min Yang
Journal:  Diabetes Metab J       Date:  2022-03-07       Impact factor: 5.376

Review 6.  Twenty Years of Ferroportin Disease: A Review or An Update of Published Clinical, Biochemical, Molecular, and Functional Features.

Authors:  L Tom Vlasveld; Roel Janssen; Edouard Bardou-Jacquet; Hanka Venselaar; Houda Hamdi-Roze; Hal Drakesmith; Dorine W Swinkels
Journal:  Pharmaceuticals (Basel)       Date:  2019-09-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.